http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4712978-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3219
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-579
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-262
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-70
filingDate 2000-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-4712978-B2
titleOfInvention Novel triazine-type antidote and use thereof
abstract An affinity ligand-matrix conjugate comprises the matrix and conjugated thereto by the group Z, a ligand having general formula (I): wherein one X is N and the other X is N, CCL or CCn; A<SUB>1 </SUB>and A<SUB>2 </SUB>are each independently O, S or N-R<SUB>1 </SUB>and R<SUB>1 </SUB>is H, C<SUB>1-6 </SUB>alkyl, C<SUB>1-6 </SUB>hydroxyalkyl, benzyl or beta-phenylethyl; B<SUB>1 </SUB>and B<SUB>2 </SUB>are each independently an optionally substituted hydrocarbon linkage containing from 1 to 10 carbon atoms; D<SUB>1 </SUB>is H or a primary amino, secondary amino, tertiary amino, quaternary ammonium, imidazole, guanidine or amidino group; and D<SUB>2 </SUB>is a secondary amino, tertiary amino, quaternary ammonium, imidazole, guanidine or amidino group; or B<SUB>2</SUB>-D<SUB>2 </SUB>is -CHCOOH-(CH<SUB>2</SUB>)<SUB>3-4</SUB>-NH<SUB>2</SUB>; and p is 0 or 1. Such conjugates are useful for the separation, isolation, purification, characterization, identification or quantification of an endotoxin.
priorityDate 1999-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4562251-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02193072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57183712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9710887-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152

Total number of triples: 36.